S'abonner

Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease - 05/03/15

Doi : 10.1016/j.jaci.2014.07.012 
Nicola Cotugno, MD a, b, , Andrea Finocchi, MD, PhD a, b, , Alberto Cagigi, PhD a, Gigliola Di Matteo, PhD a, b, Maria Chiriaco, PhD a, b, Silvia Di Cesare, PhD a, b, Paolo Rossi, MD, PhD a, b, Alessandro Aiuti, MD, PhD a, b, c, , Paolo Palma, MD, PhD a, , , Iyadh Douagi, PhD d, ,
a University Department of Pediatrics, Unit of Immune and Infectious Diseases, Children's Hospital Bambino Gesù, Rome, Italy 
b Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy 
c TIGET, Scientific Institute San Raffaele, Milan, Italy 
d Center for Hematology and Regenerative Medicine (HERM), Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden 

Corresponding authors: Alessandro Aiuti, MD, PhD, University Department of Pediatrics, Children Hospital Bambino Gesù, Department of Public Health and Cellular Biology, Tor Vergata, Rome, Italy.∗∗Paolo Palma, MD, PhD, University Department of Pediatrics, Children Hospital Bambino Gesù, Department of Public Health and Cellular Biology, Tor Vergata, Rome, Italy.∗∗∗Iyadh Douagi, PhD, Center for Hematology and Regenerative Medicine (HERM), Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

Abstract

Background

Chronic granulomatous disease (CGD) is a primary immune deficiency characterized by a defect in reactive oxygen species production. Although the effect of CGD mainly reflects on the phagocytic compartment, B-cell responses are also impaired in patients with CGD.

Objective

We sought to investigate how defective gp91phox expression in patients with CGD and CGD carriers might affect the B-cell compartment and maintenance of long-term memory.

Methods

We studied the B-cell compartment of patients with CGD in terms of phenotype and ability to produce reactive oxygen species and proliferate on stimuli differently directed to the B-cell receptor and Toll-like receptor 9. We further studied their capacity to maintain long-term memory by measuring cellular and serologic responses to measles.

Results

We show that the memory B-cell compartment is impaired among patients with CGD, as indicated by reduced total (CD19+CD27+) and resting (CD19+CD27+CD21+) memory B cells in parallel to increased naive (CD19+CD27IgD+) B-cell frequencies. Data on CGD carriers reveal that such alterations are related to gp91phox expression. Moreover, proliferative capabilities of B cells on selective in vitro stimulation of B-cell receptor or Toll-like receptor 9 pathways were reduced in patients with CGD compared with those seen in age-matched healthy control subjects. Significantly lower measles-specific antibody levels and antibody-secreting cell numbers were also observed, indicating a poor ability to maintain long-term memory in these patients.

Conclusion

Altogether, our data suggest that patients with CGD present a defective B-cell compartment in terms of frequencies of memory B cells, response to in vitro stimulation, and maintenance of long-term antigen-specific memory.

Le texte complet de cet article est disponible en PDF.

Key words : Chronic granulomatous disease, B cell, proliferation, long-term memory, measles, memory B-cell compartment, reactive oxygen species deficiency

Abbreviations used : Anti-Ig, ASC, BCR, CGD, HC, NADPH, PMA, PWM, ROS, TLR


Plan


 Supported by grants obtained from the Bambino Gesù Children's Hospital and the Karolinska Institutet. Also supported by Cell-PID HEALTH F5-2010-261387, EUROCGD project (ERA-NET E-Rare: “European research projects on rare diseases”), Italian Ministry of Health (Progetto Giovani Ricercatori GR-2008-57 to A.F.).
 Disclosure of potential conflict of interest: This study was supported by grants obtained from the Bambino Gesù Children's hospital and from the Karolinska Institutet. A. Finocchi's institution has received funding from Progetto Giovani Ricercatori. A. Aiuti's institution has received funding from the European Union. The rest of the authors declare that they have no other relevant conflicts of interest.


© 2014  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 135 - N° 3

P. 753 - mars 2015 Retour au numéro
Article précédent Article précédent
  • Adverse reactions associated with oral and parenteral use of cephalosporins: A retrospective population-based analysis
  • Eric Macy, Richard Contreras
| Article suivant Article suivant
  • IL-10/Janus kinase/signal transducer and activator of transcription 3 signaling dysregulates Bim expression in autoimmune lymphoproliferative syndrome
  • Omar Niss, Allyson Sholl, Jack J. Bleesing, David A. Hildeman

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.